Alpha 2.0
Login Register
» Articles » PMID: 26215942

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2015 Jul 29
PMID 26215942
Citations 9
Authors
David R Gandara
Primo N Lara Jr
Philip C Mack
Affiliations
Soon will be listed here.
Citing Articles

Tubulin-binding peptide RR-171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF-kappa B pathway.

Zhu D, Fang C, Yang Z, Ren Y, Yang F, Zheng S Cell Prolif. 2022; 55(5):e13241.

PMID: 35504605 PMC: 9136518. DOI: 10.1111/cpr.13241.

Challenges and Opportunities for Childhood Cancer Drug Development.

Houghton P, Kurmasheva R Pharmacol Rev. 2019; 71(4):671-697.

PMID: 31558580 PMC: 6768308. DOI: 10.1124/pr.118.016972.

Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.

Hernandez M, Bergquist J, Leiting J, Ivanics T, Yang L, Smoot R J Gastrointest Surg. 2019; 23(4):818-824.

PMID: 30756315 DOI: 10.1007/s11605-019-04109-z.

Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients.

Zhan M, Yang R, Wang H, He M, Chen W, Xu S Cancer Commun (Lond). 2018; 38(1):48.

PMID: 30016995 PMC: 6050666. DOI: 10.1186/s40880-018-0318-8.

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.

Rozeik M, Hammam O, Ali A, Magdy M, Khalil H, Anas A Electron Physician. 2017; 9(7):4708-4717.

PMID: 28894525 PMC: 5586983. DOI: 10.19082/4708.